Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Restrictive Lung Disease

Orkambi Indication Expanded to Include More Children With Cystic Fibrosis

Diana Ernst, RPh

September 9, 2022

The safety profile of Orkambi was found to be similar in patients aged 1 to less than 2 years compared with those 2 years of age and older.

Lung Infection

Inhaled Corticosteroids May Reduce Severity, Frequency of Recurrent Croup

Diana Ernst, RPh

October 21, 2021

Patients who had more than 5 episodes of croup were more likely to benefit from inhaled corticosteroids.

Smoking

Otolaryngology-Related Side Effects Following E-Cigarette Use Identified

Diana Ernst, RPh

October 4, 2021

The study authors identified 32 studies that reported on side effects following e-cigarette use.

Influenza

ACIP: Updated Vaccine Guidance for the 2021-2022 Influenza Season

Diana Ernst, RPh

September 3, 2021

Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.

Pneumonia

Treatment for Pneumocystis Pneumonia Recalled Due to Temperature Control Issue

Diana Ernst, RPh

August 13, 2021

The recall was initiated because the product had prolonged exposure to extremely cold weather during shipment.

Pneumonia

FDA Approves 20-Valent Pneumococcal Conjugate Vaccine Prevnar 20

Diana Ernst, RPh

June 16, 2021

The vaccine contains capsular polysaccharide conjugates for 7 additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) that cause invasive pneumococcal disease.